Cite
MLA Citation
Hansoo Kim et al.. “Cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy.” British journal of clinical pharmacology, vol. 86, no. 9, 2020, pp. 1703–1710. http://access.bl.uk/ark:/81055/vdc_100106937850.0x00004a